News Articles Tagged: EGFR Resistance

Navigating EGFR TKI Resistance: The Role of AZD-9291 in NSCLC Management

Learn how AZD-9291 (Osimertinib) addresses EGFR TKI resistance in NSCLC and NINGBO INNO PHARMCHEM CO.,LTD.'s contribution to pharmaceutical supply.

Navigating Resistance: The Role of Osimertinib Mesylate in Advanced NSCLC

Understand how Osimertinib Mesylate helps navigate resistance in advanced NSCLC, offering a crucial treatment pathway for patients with T790M mutations. Learn about its chemical properties.

Lapatinib: A Deeper Dive into its Mechanism and Potential in Cancer Treatment

Unpacking the complex lapatinib mechanism of action and its expanding potential in various cancer treatments, from breast to endometrial cancer.

The Dual Power of Lapatinib: Targeting HER2 and Overcoming Resistance in Cancer

Discover how Lapatinib's dual action on HER2 and EGFR, and its ability to combat multidrug resistance, is revolutionizing cancer treatment strategies.